CASE REPORT: LIVER ABSCESS-ASSOCIATED BACTEREMIA CAUSED BY E. COLI AND E. RAFFINOSUS
Nội dung chính của bài viết
Tóm tắt
We report a clinical case of a 77-year-old male patient diagnosed with bloodstream infection accompanied
by a liver abscess caused by Escherichia coli and Enterococcus raffinosus. The patient had a medical history
of hypertension and benign prostatic hyperplasia. He initially presented with fever and right upper quadrant
abdominal pain. On the third day of illness, he was admitted to a district-level hospital with a presumptive
diagnosis of sepsis. After two days of empirical antibiotic treatment without clinical improvement, he was referred to a provincial hospital, where the diagnosis of sepsis with liver abscess was made, along with known comorbidities of benign prostatic hyperplasia and hypertension. He received a combination of cefoperazone, gentamicin, and metronidazole; however, the patient remained febrile, and blood cultures grew E. coli (antibiotic susceptibility testing was not available). He was subsequently transferred to Bach Mai Hospital. Initial treatment with meropenem and percutaneous aspiration of the liver abscess led to
gradual clinical improvement. Blood and abscess fluid cultures at our hospital revealed coinfection with E.
coli and E. raffinosus. Targeted antibiotic therapy with meropenem and vancomycin was initiated, resulting
in marked clinical improvement and eventual hospital discharge. This case underscores the importance of considering polymicrobial infections and the crucial role of early source control in managing intraabdominal sepsis.
Chi tiết bài viết
Từ khóa
E. coli, E. raffinosus, Liver abscess, Bacteremia
Tài liệu tham khảo
2. Dat V.Q., Vu H.N., Nguyen The H., et al. (2017). Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam:
aetiology, drug resistance, and treatment outcome. BMC Infect Dis, 17(1), 493.
3. de Lastours V., Laouénan C., Royer G., et al. (2020). Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it. J Antimicrob Chemother, 75(8), 2334-2343.
4. Tan C.-K., Lai C.-C., Wang J.-Y., et al. (2010). Bacteremia caused by non-faecalis and nonfaecium enterococcus species at a Medical center in
Taiwan, 2000 to 2008. J Infect, 61(1), 34-43.
5. Jia W., Li G., and Wang W. (2014). Prevalence and Antimicrobial Resistance of Enterococcus Species: A Hospital-Based Study in China.
International Journal of Environmental Research and Public Health, 11(3), 3424-3442.
6. Toc D.A., Pandrea S.L., Botan A., et al. (2022). Enterococcus raffinosus, Enterococcus durans, and Enterococcus avium Isolated from a
Tertiary Care Hospital in Romania-Retrospective Study and Brief Review. Biology, 11(4), 598.
7. Sapico F.L., Canawati H.N., Ginunas V.J., et al. (1989). Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?. J Clin Microbiol, 27(9), 2091-2095.
8. Lee Y.W., Lim S.Y., Jung J., et al. (2022). Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients. Eur J Clin
Microbiol Infect Dis, 41(3), 415-420.
9. Coombs G.W., Daley D.A., Shoby P., et al. (2023). Australian Group on Antimicrobial Resistance (AGAR), Australian Enterococcal Surveillance
Outcome Program (AESOP) Bloodstream Infection Annual Report 2022. Commun Dis Intell (2018), 47.
10. Johansson N., Kalin M., Tiveljung-Lindell A., et al. (2010). Etiology of community-acquired pneumonia: increased microbiological yield with
new diagnostic methods. Clin Infect Dis, 50(2), 202-209.